NCT00699751 2026-02-23
ALSYMPCA
Bayer
Phase 3 Completed
Clinical Trials
5 trialsNCT00286091 2018-10-17
Study on Prolonging Bone Metastasis-Free Survival in Men With Hormone Refractory Prostate Cancer
Amgen
Phase 3 Completed
NCT00928252 2017-08-14
Chemotherapy Response Monitoring With 18F-choline PET/CT in Hormone Refractory Prostate Cancer
Queen's Medical Center
Phase 1/2 Completed
NCT00629525 2015-03-03
RAD001 in Patients With Metastatic, Hormone-Refractory Prostate Cancer
Duke University
Phase 2 Completed
NCT00906243 2012-04-04
RNActive®-Derived Therapeutic Vaccine
University of Florida
Phase 1/2 Terminated